Meyer D. Glantz

ORCID: 0000-0003-3935-241X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Substance Abuse Treatment and Outcomes
  • Child and Adolescent Psychosocial and Emotional Development
  • Mental Health Treatment and Access
  • Opioid Use Disorder Treatment
  • Schizophrenia research and treatment
  • Health disparities and outcomes
  • Cannabis and Cannabinoid Research
  • Homelessness and Social Issues
  • Attention Deficit Hyperactivity Disorder
  • Neurotransmitter Receptor Influence on Behavior
  • Alcohol Consumption and Health Effects
  • Resilience and Mental Health
  • Prenatal Substance Exposure Effects
  • Gambling Behavior and Treatments
  • Behavioral Health and Interventions
  • Mental Health Research Topics
  • Cognitive Abilities and Testing
  • Smoking Behavior and Cessation
  • Functional Brain Connectivity Studies
  • Employment and Welfare Studies
  • Advanced MRI Techniques and Applications
  • Migration, Health and Trauma
  • Advanced Neuroimaging Techniques and Applications
  • Early Childhood Education and Development
  • Maternal Mental Health During Pregnancy and Postpartum

National Institute on Drug Abuse
2012-2023

National Institutes of Health
2006-2021

University of Vermont
2021

University of California, San Diego
2019

Collaborative Research Group
2018

Wesleyan University
2004

Clinical Research Services
1998

Donald J. Hagler SeanN. Hatton M. Daniela Cornejo Carolina Makowski Damien A. Fair and 95 more Anthony Steven Dick Matthew T. Sutherland B. J. Casey Deanna M. Barch Michael P. Harms Richard Watts James M. Bjork Hugh Garavan Laura Hilmer Christopher J. Pung Chelsea S. Sicat Joshua Kuperman Hauke Bartsch Feng Xue Mary M. Heitzeg Angela R. Laird Thanh T. Trinh Raúl González Susan F. Tapert Michael C. Riedel Lindsay M. Squeglia Luke W. Hyde Monica D. Rosenberg Eric Earl Katia Delrahim Howlett Fiona C. Baker Mary Soules Jazmin Diaz Octavio Ruiz de Leon Wesley K. Thompson Michael C. Neale Megan M. Herting Elizabeth R. Sowell Ruben P. Alvarez Samuel W. Hawes Mariana Sánchez Jerzy Bodurka Florence J. Breslin Amanda Sheffield Morris Martin P. Paulus W. Kyle Simmons Jon̈athan R. Polimeni André van der Kouwe Andrew S. Nencka Kevin M. Gray Carlo Pierpaoli John A. Matochik Antonio Noronha Will M. Aklin Kevin P. Conway Meyer D. Glantz Elizabeth A. Hoffman A. Roger Little Marsha F. Lopez Vani Pariyadath Susan R.B. Weiss Dana L. Wolff‐Hughes Rebecca DelCarmen‐Wiggins Sarah W. Feldstein Ewing Óscar Miranda-Domínguez Bonnie J. Nagel Anders Perrone Darrick Sturgeon Aimée Goldstone Adolf Pfefferbaum Kilian M. Pohl Devin Prouty Kristina A. Uban Susan Y. Bookheimer Mirella Dapretto Adriana Galván Kara Bagot Jay N. Giedd M. Alejandra Infante Joanna Jacobus Kevin Patrick Paul D. Shilling Rahul S. Desikan Yi Li Leo P. Sugrue Marie T. Banich Naomi P. Friedman John K. Hewitt Christian J. Hopfer Joseph T. Sakai Jody Tanabe Linda B. Cottler Sara Jo Nixon Linda Chang Christine Cloak Thomas Ernst Gloria Reeves David N. Kennedy Steve Heeringa Scott Peltier

10.1016/j.neuroimage.2019.116091 article EN NeuroImage 2019-08-12

The comorbidity of mental disorders and substance dependence is well documented, but prospective investigations in community samples are rare. This investigation examines the role primary as risk factors for later onset nicotine, alcohol illicit drug use, abuse with abuse.

10.1111/j.1360-0443.2010.02902.x article EN Addiction 2010-03-10

ContextAmong illicit substance use disorders, marijuana disorders are the most prevalent in population. Yet, information about prevalence of current Diagnostic and Statistical Manual Mental Disorders, Fourth Edition (DSM-IV) how has changed is lacking.ObjectiveTo examine changes use, abuse, dependence United States between 1991-1992 2001-2002.Design, Setting, ParticipantsFace-to-face interviews were conducted 2 large national surveys 10 years apart: National Longitudinal Alcohol...

10.1001/jama.291.17.2114 article EN JAMA 2004-05-04

Substance use is a major cause of disability globally. This has been recognized in the recent United Nations Sustainable Development Goals (SDGs), which treatment coverage for substance disorders identified as one indicators. There have no estimates this cross‐nationally, making it difficult to know what baseline that SDG target. Here we report data from World Health Organization (WHO)'s Mental Surveys (WMHS), based on representative community household surveys 26 countries. We assessed...

10.1002/wps.20457 article EN World Psychiatry 2017-09-21
Bader Chaarani Sage Hahn Nicholas Allgaier Shana Adise Max M. Owens and 95 more Anthony Juliano Dekang Yuan Hannah Loso Alexandra Ivanciu Matthew D. Albaugh Julie A. Dumas Scott Mackey Jennifer Laurent Masha Y. Ivanova Donald J. Hagler M. Daniela Cornejo Sean N. Hatton Arpana Agrawal Laika D. Aguinaldo Lia Ahonen Will M. Aklin Andrey P. Anokhin Judith A. Arroyo Shelli Avenevoli Debra Babcock Kara Bagot Fiona C. Baker Marie T. Banich Deanna M. Barch Hauke Bartsch Arielle Baskin–Sommers James M. Bjork D. Blachman-Demner Michele Bloch Ryan Bogdan Susan Y. Bookheimer Florence J. Breslin Sandra A. Brown Finnegan J. Calabro Vince D. Calhoun B.J. Casey L. Chang Duncan B. Clark Christine Cloak R. Todd Constable K. Constable Robin P. Corley Linda B. Cottler Stefany Coxe Richard Dagher Anders M. Dale Mirella Dapretto Rebecca DelCarmen‐Wiggins Anthony Steven Dick E. K. Nico U.F. Dosenbach Gayathri J. Dowling Sarah Edwards Thomas Ernst Damien A. Fair Chun Chieh Fan Eric Feczko Sarah W. Feldstein-Ewing Paul Florsheim John J. Foxe Edward G. Freedman Naomi P. Friedman Stacia R. Friedman‐Hill Bernard F. Fuemmeler Adriana Gálvan Dylan G. Gee Jay N. Giedd Meyer D. Glantz Paul E.A. Glaser Job Godino Marybel R. Gonzalez Raúl González Steven Grant Kevin M. Gray Frank Haist Michael P. Harms Samuel W. Hawes Andrew C. Heath Steven G. Heeringa Mary M. Heitzeg Robert Hermosillo Megan M. Herting John M. Hettema John K. Hewitt Charles J. Heyser Elizabeth A. Hoffman Katia Delrahim Howlett Rebekah S. Huber Marilyn A. Huestis Luke W. Hyde William G. Iacono M. Alejandra Infante Okan Irfanoglu Amal Isaiah Satish Iyengar

10.1038/s41593-021-00867-9 article EN Nature Neuroscience 2021-06-07

The Adolescent Brain Cognitive Development (ABCD) Study of 11,880 youth incorporates a comprehensive range measures assessing predictors and outcomes related to mental health across childhood adolescence in participating youth, as well information about family history. We have previously described the logic content assessment battery at Baseline 1-year follow-up. Here, we describe changes that issues clarifications emerged, additions 2-, 3-, 4-, 5-year follow-ups. capitalize on recent...

10.1016/j.dcn.2021.101031 article EN cc-by-nc-nd Developmental Cognitive Neuroscience 2021-10-29

Continued progress in etiological research and prevention science requires more precise information concerning the specific stages at which socio-demographic variables are implicated most strongly transition from initial substance use to dependence. The present study examines prospective associations between subsequent onset of alcohol drug dependence using data National Comorbidity Survey (NCS) NCS Follow-up survey (NCS-2).

10.1111/j.1360-0443.2009.02622.x article EN Addiction 2009-06-22

Background Although mental disorders have been shown to predict subsequent substance disorders, it is not known whether could be cost-effectively prevented by large-scale interventions aimed at prior disorders. experimental intervention the only way resolve this uncertainty, a logically question associations of with are strong enough justify mounting such an intervention. We investigated in study using simulations estimate number that might under several hypothetical scenarios focused on...

10.1017/s0033291708004510 article EN Psychological Medicine 2008-12-02

Background The ‘gateway’ pattern of drug initiation describes a normative sequence, beginning with alcohol and tobacco use, followed by cannabis, then other illicit drugs. Previous work has suggested that ‘violations’ this sequence may be predictors later problems but determinants were not considered. We have examined the role pre-existing mental disorders sociodemographics in explaining predictive effects violations using data from US National Comorbidity Survey Replication (NCS-R). Method...

10.1017/s0033291708003425 article EN Psychological Medicine 2008-05-09

Over the past 20 years we have accumulated a greater knowledge and understanding of genetic, neurobiological, behavioral factors that may be associated with young people initiating use drugs other substances to progressing from abuse dependence. This suggests individuals “predisposed” substance disorders (SUD) actual engagement in these behaviors depends on their environmental experiences micro macro levels. paper summarizes this base supports developmental framework examines interaction...

10.3109/10826084.2012.663280 article EN Substance Use & Misuse 2012-06-07
Yi Li Wesley K. Thompson Chase Reuter Ryan M. Nillo Terry L. Jernigan and 95 more Anders M. Dale Leo P. Sugrue Julian Brown Robert F. Dougherty Andreas M. Rauschecker Jeffrey D. Rudie Deanna M. Barch Vince D. Calhoun Donald J. Hagler Sean N. Hatton Jody Tanabe Andrew T. Marshall Kenneth J. Sher Steven G. Heeringa Robert Hermosillo Marie T. Banich Lindsay M. Squeglia James M. Bjork Robert A. Zucker Michael C. Neale Megan M. Herting Chandni Sheth Rebekah S. Huber Gloria Reeves John M. Hettema Katia Delrahim Howlett Christine Cloak Arielle Baskin–Sommers Kristina M. Rapuano Raúl González Nicole R. Karcher Angela R. Laird Fiona C. Baker Regina Smith James Elizabeth R. Sowell Anthony Steven Dick Samuel W. Hawes Matthew T. Sutherland Kara Bagot Jerzy Bodurka Florence J. Breslin Amanda Sheffield Morris Martin P. Paulus Kevin M. Gray Elizabeth A. Hoffman Susan R.B. Weiss Nishadi Rajapakse Meyer D. Glantz Bonnie J. Nagel Sarah Feldstein Ewing Aimée Goldstone Adolf Pfefferbaum Devin Prouty Monica D. Rosenberg Susan Y. Bookheimer Susan F. Tapert M. Alejandra Infante Joanna Jacobus Jay N. Giedd Paul D. Shilling Natasha E. Wade Kristina A. Uban Frank Haist Charles J. Heyser Clare E. Palmer Joshua Kuperman John K. Hewitt Linda B. Cottler Amal Isaiah Linda Chang Sarah Edwards Thomas Ernst Mary M. Heitzeg Leon I. Puttler Chandra Sripada William G. Iacono Mónica Luciana Duncan B. Clark Beatríz Luna Claudiu Schirda John J. Foxe Edward G. Freedman Michael J. Mason Erin McGlade Perry F. Renshaw Deborah Yurgelun‐Todd Matthew D. Albaugh Nicholas Allgaier Bader Chaarani Alexandra Potter Masha Y. Ivanova Krista M. Lisdahl K. Elizabeth Hermine H. Maes Ryan Bogdan

Incidental findings (IFs) are unexpected abnormalities discovered during imaging and can range from normal anatomic variants to requiring urgent medical intervention. In the case of brain magnetic resonance (MRI), reliable data about prevalence significance IFs in general population limited, making it difficult anticipate, communicate, manage these findings.To determine overall MRI nonclinical pediatric as well rates specific for which clinical referral is recommended.This cohort study was...

10.1001/jamaneurol.2021.0306 article EN JAMA Neurology 2021-03-22

Drug abuse research and theory has become much more sophisticated over the last 2 decades, some of advancements parallel concepts that are part developmental psychopathology approach. The application perspective to recent drug findings can provide a greater understanding information point important areas future research. Among discussed here viewed from this antecedent co-occurring psychopathological conditions other problem behaviors; diversity nature of, paths to, processes outcomes...

10.1017/s0954579400004120 article EN Development and Psychopathology 2000-12-01

Abstract Background and aims The World Health Organization's (WHO's) proposed International Classification of Diseases, 11th edition (ICD‐11) includes several major revisions to substance use disorder (SUD) diagnoses. It is essential ensure the consistency within‐subject diagnostic findings throughout countries, languages cultures. To date, agreement analyses between different SUD systems have largely been based in high‐income countries clinical samples rather than general population...

10.1111/add.14482 article EN Addiction 2018-10-29
Krista M. Lisdahl Susan F. Tapert Kenneth J. Sher Raúl González Sara Jo Nixon and 95 more Sarah W. Feldstein Ewing Kevin P. Conway Alex Wallace Ryan M. Sullivan Kelah Hatcher Christine M. Kaiver Wes Thompson Chase Reuter Hauke Bartsch Natasha E. Wade Joanna Jacobus Matthew D. Albaugh Nicholas Allgaier Andrey P. Anokhin Kara Bagot Fiona C. Baker Marie T. Banich Deanna M. Barch Arielle Baskin–Sommers Florence J. Breslin Sandra A. Brown Vince D. Calhoun B.J. Casey Bader Chaarani Linda Chang Duncan B. Clark Christine Cloak R. Todd Constable Linda B. Cottler Richard Dagher Mirella Dapretto Anthony Steven Dick K. Elizabeth Nico U.F. Dosenbach Gayathri J. Dowling Damien A. Fair Paul Florsheim John J. Foxe E.G. Freedman Naomi P. Friedman Hugh Garavan Dylan G. Gee Meyer D. Glantz Paul E.A. Glaser Marybel R. Gonzalez Kylie M. Gray Steven Grant Frank Haist Samuel W. Hawes Steven G. Heeringa Robert Hermosillo Megan M. Herting John M. Hettema John K. Hewitt Charles J. Heyser Elizabeth A. Hoffman Katia Delrahim Howlett Rebekah S. Huber Marilyn A. Huestis Luke W. Hyde William G. Iacono Amal Isaiah Masha Y. Ivanova Regina Smith James Terry L. Jernigan Nicole R. Karcher Joshua Kuperman Angela R. Laird Christine L. Larson Kimberly H. LeBlanc Marsha F. Lopez Mónica Luciana Beatríz Luna Hermine H. Maes Andrew T. Marshall Michael J. Mason Erin McGlade Amanda Sheffield Morris Carrie F. Mulford Bonnie J. Nagel Gretchen N. Neigh Clare E. Palmer Martin P. Paulus Diliana Pecheva Devin Prouty Alexandra Potter Leon I. Puttler Nishadi Rajapakse J. Megan Ross Mariana Sánchez Claudiu Schirda John E. Schulenberg Chandni Sheth Paul D. Shilling Elizabeth R. Sowell

10.1016/j.drugalcdep.2021.108946 article EN Drug and Alcohol Dependence 2021-07-29
Coming Soon ...